Dissolution Testing Guidance Should Allow For Use Of Scientific Justifications
Executive Summary
Scientific justifications to decide critical elements of dissolution testing should be allowed in an FDA quality by design guidance, the agency's Advisory Committee for Pharmaceutical Science unanimously agreed at its Oct. 25 meeting